MedTrace Logo

Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms

NCT01523132 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 545

Last updated 2016-04-06

No results posted yet for this study

Summary

The study is a prospective cohort study following breast cancer patients from before surgery to one year after. The aims of the study are to determine risk factors that predispose to the development of persistent pain.

Conditions

Sponsors & Collaborators

  • Danish Breast Cancer Cooperative Group

    collaborator OTHER

  • Danish Cancer Society

    collaborator OTHER

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Kenneth Geving Andersen, MD · Rigshospitalet, Denmark

  • Henrik Kehlet, MD, PhD · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01523132 on ClinicalTrials.gov